Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04661657 · ClinicalTrials.gov registry record
COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 52
- Enrollment target
NCT04661657 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 52 participants.
The verdict
NCT04661657 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
COLUMBIA CARDS is a pilot study to understand how COVID-19 affects the heart. It is known that COVID-19 can affect the heart in different ways. COLUMBIA CARDS is studying why some COVID-19 survivors develop clinical conditions such as heart inflammation, fluid buildup, blood clots, and other cardiac problems during or after their COVID-19 illness, and why other ones do not. In this study, we will use cardiovascular magnetic resonance (CMR) and transthoracic echocardiography (TTE) to better understand the impact of COVID-19 on the heart.
Interventions
- OTHER Transthoracic echocardiogram (TTE)
- OTHER Cardiovascular Magnetic Resonance (CMR) Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2020-12-28 |
| Est. Completion | 2022-01-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04661657
The ClinicalTrials.gov registry entry for NCT04661657 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transthoracic echocardiogram (TTE) is the first listed.
NCT04661657 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04661657 about?
NCT04661657 is a clinical study titled "COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry". COLUMBIA CARDS is a pilot study to understand how COVID-19 affects the heart. It is known that COVID-19 can affect the heart in different ways. COLUMBIA CARDS is studying why some COVID-19 survivors develop clinical conditions such as heart inflammation, fluid buildup, blood clots, and other cardiac...
What is the current status of trial NCT04661657?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2020-12-28. Estimated completion is 2022-01-22.
What interventions are being tested in trial NCT04661657?
The interventions under investigation include: Transthoracic echocardiogram (TTE) (OTHER), Cardiovascular Magnetic Resonance (CMR) Imaging (OTHER).
Who is sponsoring clinical trial NCT04661657?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.